PARIS — Around 15 vaccine candidates are being developed in the battle against tuberculosis to compensate for the poor efficacy of the Bacillus Calmette-Guérin (BCG) vaccine. Three of these candidates ...

A new study from the University of Pittsburgh Center for Vaccine Research published today in the Journal of Experimental Medicine describes a previously unappreciated role for a class of immune cells ...

Share on Facebook. Opens in a new tab or window Share on Bluesky. Opens in a new tab or window Share on X. Opens in a new tab or window Share on LinkedIn. Opens in a new tab or window N-acetylcysteine ...

Texas A&M College of Medicine is leading a consortium of research hospitals and medical schools in a Phase 4 trial to determine if the century-old tuberculosis vaccine can help blunt the damage from ...

LONDON (Reuters) - A new experimental drug that may fight drug-resistant strains of the lung disease tuberculosis is being tested in South Africa, where the first patient has been enrolled into a ...

Tuberculosis remains the world's leading infectious killer, claiming an estimated 1.23 million lives last year, the UN health ...